Seanad debates

Thursday, 27 November 2003

Address by Ms Dana Rosemary Scallon, MEP.

 

The Leader will recall I tried to get this aspect debated when the House held an excellent debate on stem cell research, a debate that was far better than the one that occurred in another place. Does Ms Scallon consider that we should allow drugs into this country no matter how efficacious if, in any part of their development, the toxicity has been tested on embryonic stem cells, because this is happening more and more? Should we even countenance allowing these companies to have factories here given that they use biotechnology companies which are very profitable for testing drugs for toxicity and even if the drugs which are tested on embryonic stem cells are not made here, although I gather this will become an increasingly important aspect?

Comments

No comments

Log in or join to post a public comment.